Live Breaking News & Updates on Adam muchmore

Stay informed with the latest breaking news from Adam muchmore on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Adam muchmore and stay connected to the pulse of your community

What's the holdup in full FDA vaccine approval?

What’s the holdup in full FDA vaccine approval?
Tom Avril
The Philadelphia Inquirer
More than eight months ago, large studies found that both the Pfizer-BioNTech and Moderna COVID-19 vaccines reduced the risk of illness by more than 90%. Yet the U.S. Food and Drug Administration has not yet granted them full approval, to the dismay of public-health officials eager to boost vaccination rates as the delta variant sends infections skyward.
So what’s the holdup?
Part of the reason, according to experts in drug regulation, may be simply that the agency can afford to take the time.
In December, the FDA authorized the first two vaccines for emergency use, and did so for a third in February. Those authorizations, though based on extensive, rigorous research, are temporary in nature. Before granting permanent approval (“licensure”), the agency can spend months to make triply sure that all regulatory requirements are met, given that the vaccines are available for all who want them in the meantime.

Pennsylvania-state-university , Pennsylvania , United-states , Philadelphia , Greer-donley , Damon-leichty , Tom-avril , Susans-ellenberg , Indiana-university , University-of-pennsylvania-perelman-school-medicine , University-of-pittsburgh-law-school , Drug-administration

Full FDA approval of covid-19 vaccines might lead more people to get them. What's the holdup?

Full FDA approval of covid-19 vaccines might lead more people to get them. What’s the holdup?
The Philadelphia Inquirer
AP

TribLIVE's Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.
PHILADELPHIA — More than eight months ago, large studies found that both the Pfizer-BioNTech and Moderna covid-19 vaccines reduced the risk of illness by more than 90%. Yet the U.S. Food and Drug Administration has not yet granted them full approval, to the dismay of public-health officials eager to boost vaccination rates as the delta variant sends infections skyward.
So what’s the holdup?

Penn-state-university , Pennsylvania , United-states , Philadelphia , Greer-donley , Damon-leichty , Susans-ellenberg , Indiana-university , University-of-pennsylvania-perelman-school-medicine , University-of-pittsburgh-law-school , Drug-administration , Us-justice-department